LDHAα , a lactate dehydrogenase A isoform, promotes glycolysis and tumor progression
The FEBS Journal · 2025
DOI: 10.1111/febs.17374 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Bingqing Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: L-Lactate Dehydrogenase, Glycolysis, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Tianjin Science and Technology Project, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Lactate dehydrogenase A (LDHA) is upregulated in multiple cancer types and contributes to the Warburg effect. Several studies have found that many tumor‐related genes have subtypes and play important roles in promoting cancer development. Here, we identified a novel LDHA transcript, which produced a new protein 3 kDa larger than LDHA, which we named LDHAα. We found that multiple cancer cell lines express LDHAα, and ectopic expression of LDHAα led to a higher proliferation and migration rate in vitro . Ectopic expression of LDHAα could also promote tumor cell growth in vivo . Conversely, deletion of LDHAα by CRISPR‐sgRNA significantly inhibited the growth of tumor cells. LDHAα was found to be mainly located in the cytoplasm, and overexpression or deletion of LDHAα could significantly affect the glucose uptake and lactate production of tumor cells. Further investigation showed that c‐MYC and FOXM1 could markedly modulate the expression of both LDHA and LDHAα, especially c‐MYC. We found that a small molecular compound targeting LDHA could also inhibit the enzyme activity of LDHAα. LDHAα, LDHA and c‐MYC expression was significantly higher in human acute lymphocytic leukemia and colorectal cancer tissue specimens compared to normal controls. In conclusion, our study identified LDHAα as a subtype of LDHA and highlighted its critical role in tumor metabolism, providing a potential new therapeutic target for tumor diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Tianjin Institutes of Health Science, Tianjin, China.
- Tianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin Eye Hospital & Eye Institute, NanKai University, Tianjin, China.
- Laboratory of Immunology and Inflammation, Department of Biotechnology, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
ORCID-Profile: Bingqing Huang, Huijun Wang
Förderung
- National Natural Science Foundation of China
- Tianjin Science and Technology Project
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- Tianjin Health Science and Technology Project
Zitieren
APA
Huang, B., Shen, W., Jia, Y., Qin, L., Wang, H., Sun, Q., Xiao, Z., Zhang, R., & Wang, H. (2025). LDHAα , a lactate dehydrogenase A isoform, promotes glycolysis and tumor progression. The FEBS Journal. https://doi.org/10.1111/febs.17374
Vancouver
Huang B, Shen W, Jia Y, Qin L, Wang H, Sun Q, et al. LDHAα , a lactate dehydrogenase A isoform, promotes glycolysis and tumor progression. The FEBS Journal. 2025. doi:10.1111/febs.17374
BibTeX
@article{Huang2025,
author = {Huang, Bingqing and Shen, Wencui and Jia, Yujiao and Qin, Li and Wang, Haoxu and Sun, Qi and Xiao, Zhijian and Zhang, Rongxin and Wang, Huijun},
title = {LDHAα , a lactate dehydrogenase A isoform, promotes glycolysis and tumor progression},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.17374}
}
EUVIMED